OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: ms

Can Nutra Pharma Corporation (OTCQB: NPHC) Control Costs and Post Positive Gross Profits from Sale of Pharmaceutical Products?

After sinking to a low of 0.0038 earlier this month the share price of Nutra Pharma Corporation (OTCQB: NPHC) managed to climb to a six-month high of 0.0230 on Wednesday but the biotechnology company has found it difficult to remain … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

Does BrainStorm Cell Therapeutics (OTCBB: BCLI) Have What it Takes to Halt ALS with Stem Cell Treatment?

While BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) announced on Tuesday their intention to sell 19.8 million shares of their common stock at 29 cents each, effectively raising an estimated $4.78 million, investors found little reason to ignite a buying frenzy … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

BrainStorm Cell Therapeutics (OTCBB: BCLI) Share Price and Volume Jump on Research Analyst Report Despite Absence of Revenue and Products

Take a company like BrainStorm Cell Therapeutics (OTCBB: BCLI), which has been trading around the 0.25 – 0.30 with minimal volume over the past several months, throw in a “Buy” recommendation from a research analyst that predicts share price to … Continue reading

Posted in Articles, OTC Bulletin Board, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment

With FDA Approval Now Secure What Path Will Avanir Pharmaceuticals Travel?

Four years ago Avanir Pharmaceuticals (NASDAQ: AVNR) had to swallow the bitter pill of rejection as the FDA turned down their application for Neudexta due to concerns over heart rhythm safety, as shares tumbled south many questioned whether the pharmaceutical … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment